CD38 expressed on human monocytes: a coaccessory molecule in the superantigen-induced proliferation.
This work analyzes the hypothesis that human CD38 may cooperate with MHC Class II by acting as coreceptor in a superantigen-induced activation. The initial evidence is that CD38 ligation by specific monoclonal antibodies inhibits superantigen-induced T lymphocyte proliferation. Inhibitory effects become apparent after engagement of CD38 expressed by monocytes, whereas ligation of CD38 expressed by T lymphocytes does not apparently affect activation. The inhibition requires a cell-to-cell interaction, followed by the relevant transmembrane signaling that is reproduced by CD38 ligation. Indeed, CD38 ligation on monocytes induces tyrosine phosphorylation of several intracellular proteins including the protooncogene product c-cbl and the fgr and hck tyrosine kinases. The receptorial nature of the CD38-mediated events is confirmed by the observation of an intracellular calcium flux in monocytes secondary to CD38 ligation. These effects are additive with the similar events elicited by MHC Class II ligation, a likely indication that CD38 and MHC Class II share a common activation pathway. This conclusion is strengthened by results of comodulation experiments, indicating that CD38 and MHC Class II display lateral associations on monocytes. These results attribute to CD38 expressed by monocytes a role in the transduction of signal(s) involved in superantigen-induced activation, operating in synergy with MHC Class II.
Zilber
M T
MT
Institut National de la Santé et de la Recherche Médicale U396, Institut d'Hématologie, Hôpital Saint-Louis, 75010 Paris, France.
Gregory
S
S
Mallone
R
R
Deaglio
S
S
Malavasi
F
F
Charron
D
D
Gelin
C
C
D036541:ADP-ribosyl Cyclase; D051997:ADP-ribosyl Cyclase 1; D015703:Antigens, CD; D000943:Antigens, Differentiation / Q000096:biosynthesis* / Q000276:immunology; D002118:Calcium / Q000378:metabolism; D005434:Flow Cytometry; D016166:Free Radical Scavengers / Q000378:metabolism; D006801:Humans; D008213:Lymphocyte Activation; D008562:Membrane Glycoproteins; D009000:Monocytes / Q000276:immunology / Q000378:metabolism*; D009244:NAD+ Nucleosidase / Q000096:biosynthesis* / Q000276:immunology; D010766:Phosphorylation; D011233:Precipitin Tests; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D011518:Proto-Oncogene Proteins / Q000378:metabolism; D050721:Proto-Oncogene Proteins c-cbl; D016601:RNA-Binding Proteins; D015398:Signal Transduction; D018089:Superantigens / Q000378:metabolism*; D013601:T-Lymphocytes / Q000378:metabolism; D014443:Tyrosine / Q000378:metabolism; D044767:Ubiquitin-Protein Ligases
D015703:Antigens, CD; D000943:Antigens, Differentiation; D016166:Free Radical Scavengers; D008562:Membrane Glycoproteins; D011518:Proto-Oncogene Proteins; D016601:RNA-Binding Proteins; D018089:Superantigens; D014443:Tyrosine; D050721:Proto-Oncogene Proteins c-cbl; C118307:RNF7 protein, human; D044767:Ubiquitin-Protein Ligases; D011505:Protein-Tyrosine Kinases; D036541:ADP-ribosyl Cyclase; C498154:CD38 protein, human; D009244:NAD+ Nucleosidase; D051997:ADP-ribosyl Cyclase 1; C067419:CBL protein, human; D002118:Calcium